It is crucially important to discover the relationships between genes and microRNAs (miRNAs) in cancer. Thus, we proposed a combined bioinformatics method integrating Pearson’s correlation coefficient (PCC), Lasso, and causal inference method (IDA) to identify the potential miRNA targets for stomach adenocarcinoma (STAD) using Borda count election.
MATERIALS AND METHODS:
Firstly, the ensemble method integrating PCC, IDA, and Lasso was used to predict miRNA targets. Subsequently, to validate the performance ability of this ensemble method, comparisons between verified database and predicted miRNA targets were implemented. Pathway analysis for target genes in the top 1000 miRNA-mRNA interactions was implemented to discover significant pathways. Finally, the top 10 target genes were identified based on predicted times 3.
RESULTS:
The ensemble approach was confirmed to be a feasible method to predict miRNA targets The 527 target genes of the top 1000 miRNA-mRNA interactions were enriched in 21 pathways. Of note, cell adhesion molecules (CAMs) was the most significant one. The top 10 target genes were identified based on predicted times 3, such as GABRA3, CSAG1 and PTPN7. These targets were all predicted by 4 times. Moreover, GABRA3 and CSAG1 were simultaneously targeted by miRNA-105-1, miRNA-105-2, and miRNA-767. Significantly, among these top 10 targets, PTPN7 and GABRA3-miRNA interactions owned the highest correlation with 691.
CONCLUSION:
The combined bioinformatics method integrating PCC, IDA, and Lasso might be a valuable method for miRNA target prediction, and dys-regulated expression of miRNAs and their potential targets might be prominently involved in the pathogenesis of STAD.
BertuccioP.ChatenoudL.LeviF.PraudD.FerlayJ.NegriE.MalvezziM. and VecchiaC.L., Recent patterns in gastric cancer: A global overview, International Journal of Cancer Journal International Du Cancer125 (2009), 666–673.
2.
LvS.X.GanJ.H.WangC.C.LuoE.P.HuangX.P.XieY. and HuangY., Biopsy from the base of gastric ulcer may find gastric cancer earlier, Medical Hypotheses76 (2010), 249–250.
3.
BergerA.C.FarmaJ.ScottW.J.FreedmanG.WeinerL.ChengJ.D.WangH. and GoldbergM., Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival, Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology23 (2005), 4330–4337.
4.
KunzP.L.GubensM.FisherG.A.FordJ.M.LichtensztajnD.Y. and ClarkeC.A., Long-term survivors of gastric cancer: A California population-based study, Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology30 (2012), 3507–3515.
5.
WangJ.WangQ.HongL.BoH.WeiZ. and ChengY., MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer, Cancer Letters297 (2010), 137–143.
6.
CroceC.M., 27 Causes and consequences of microRNA dysregulation in cancer, Cancer Journal18 (2012), 215–222.
7.
FriedmanR.FarhK.BurgeC. and BartelD., Most mammalian mRNAs are conserved targets of microRNAs, Genome Research19 (2009), 92–105.
8.
XuC.LuY.PanZ.ChuW.LuoX.LinH.XiaoJ.ShanH.WangZ. and YangB., The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes, Journal of Cell Science120 (2007), 3045–3052.
9.
ChenJ.F.MandelE.M.ThomsonJ.M.WuQ.CallisT.E.HammondS.M.ConlonF.L. and WangD.Z., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation, Nature Genetics38 (2006), 228–233.
10.
Esquela-KerscherA. and SlackF.J., Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, Nature Reviews Cancer6 (2006), 259–269.
11.
LujambioA. and LoweS.W., The microcosmos of cancer, Nature482 (2012), 347–355.
12.
EnrightA.J.JohnB.GaulU.TuschlT.SanderC. and MarksD.S., MicroRNA targets in Drosophila, Genome Biology5 (2003), R1.
13.
KrekA.GrünD.PoyM.N.WolfR.RosenbergL.EpsteinE.J.MacmenaminP.PiedadeI.D.GunsalusK.C. and StoffelM. et al., Combinatorial microRNA target predictions, Nature Genetics37 (2005), 495–500.
14.
LiuB.LiJ.TsykinA.LiuL.GaurA.B. and GoodallG.J., Exploring complex miRNA-mRNA interactions with Bayesian networks by splitting-averaging strategy, Bmc Bioinformatics10 (2009), 408.
15.
RajewskyN., MicroRNA target predictions in animals, Nature Genetics38(Suppl) (2006), 54–62.
16.
MarbachD.CostelloJ.C.KüffnerR.VegaN.M.PrillR.J.CamachoD.M.AllisonK.R.KellisM.CollinsJ.J. and StolovitzkyG., Wisdom of crowds for robust gene network inference, Nature Methods9 (2012), 796–804.
17.
LeT.D.ZhangJ.LiuL. and LiJ., Ensemble methods for MiRNA target prediction from expression data, Plos One10 (2015).
18.
SpeedT., A correlation for the 21st century, Science334 (2011), 1502–1503.
19.
MaathuisM.H.ColomboD.KalischM. and BühlmannP., Predicting causal effects in large-scale systems from observational data, Nature Methods7 (2010), 247–248.
20.
LeT.D.LiuL.TsykinA.GoodallG.J.LiuB.SunB.Y. and LiJ., Inferring microRNA-mRNA causal regulatory relationships from expression data, Bioinformatics29 (2013), 765–771.
21.
FriedmanJ.HastieT. and TibshiraniR., Regularization paths for generalized linear models via coordinate descent, Journal of Statistical Software33 (2010), 1–22.
22.
RussellN., Complexity of control of Borda count elections, 2007.
23.
LeT.D.LiuL.ZhangJ.LiuB. and LiJ., From miRNA regulation to miRNA-TF co-regulation: Computational approaches and challenges, Briefings in Bioinformatics101 (2014), 4269–4287.
24.
VergoulisT.VlachosI.S.AlexiouP.GeorgakilasG.MaragkakisM.ReczkoM.GerangelosS.KozirisN.DalamagasT. and HatzigeorgiouA.G., TarBase 6.0: Capturing the exponential growth of miRNA targets with experimental support, Nucleic Acids Research40 (2011), D222–D229.
25.
XiaoF.ZuoZ.CaiG.KangS.GaoX. and LiT., MiRecords: An integrated resource for microRNA – target interactions, Nucleic Acids Research37 (2009), D105–D110.
26.
DweepH.StichtC.PandeyP. and GretzN., MiRWalk–database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes, Journal of Biomedical Informatics44 (2011), 839–847.
27.
HsuS.D.TsengY.T.ShresthaS.LinY.L.KhaleelA.ChouC.H.ChuC.F.HuangH.Y.LinC.M. and HoS.Y., MiRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions, Nucleic Acids Research42 (2014), 78–85.
28.
LimL.P.LauN.C.Garrett-EngeleP.GrimsonA.SchelterJ.M.CastleJ.BartelD.P.LinsleyP.S. and JohnsonJ.M., Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature433 (2005), 769–773.
29.
LiuD.LiuJ.LinB.LiuS.HouR.HaoY.LiuQ.ZhangS. and IwamoriM., Lewis y regulate cell cycle related factors in ovarian carcinoma cell RMG-I in vitro via ERK and Akt signaling pathways, International Journal of Molecular Sciences13 (2012), 828–839.
30.
SchonrockN.HarveyR.P. and MattickJ.S., Long noncoding RNAs in cardiac development and pathophysiology, Circulation Research111 (2012), 1349–1362.
31.
DayR.HaoX.IlyasM.DaszakP.TalbotI.C. and ForbesA., Changes in the expression of syndecan-1 in the colorectal adenoma–carcinoma sequence, Virchows Archiv434 (1999), 121–125.
32.
OkegawaT.PongR.-C.LiY. and HsiehJ.-T., The role of cell adhesion molecule in cancer progression and its application in cancer therapy, Acta Biochimica Polonica-English Edition-51 (2004), 445–458.
33.
JohnsonJ.P., Cell adhesion molecules in the development and progression of malignant melanoma, Cancer and Metastasis Reviews18 (1999), 345–357.
34.
SpizzoG.GastlG.ObristP.WentP.DirnhoferS.BischoffS.MirlacherM.SauterG.SimonR. and StopatschinskayaS., High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer, Breast Cancer Research and Treatment86 (2004), 207–213.
35.
EichelbergC.ChunF.K.BedkeJ.HeuerR.AdamM.MochH.TerraccianoL.HinrichsK.DahlemR. and FischM., Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma, International Journal of Cancer132 (2013), 2948–2955.
36.
ChuY.-Q.YeZ.-Y.TaoH.-Q.WangY.-Y. and ZhaoZ.-S., Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma, World Journal of Gastroenterology: WJG14 (2008), 1990.
37.
PaschosK.A.CanovasD. and BirdN.C., The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis, Cellular Signalling21 (2009), 665–674.
38.
AzumaH.InamotoT.SakamotoT.KiyamaS.UbaiT.ShinoharaY.MaemuraK.TsujiM.SegawaN. and MasudaH., γ-Aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism, Cancer Research63 (2003), 8090–8096.
39.
WatanabeM.MaemuraK.OkiK.ShiraishiN.ShibayamaY. and KatsuK., Gamma-aminobutyric acid GABA and cell proliferation, focus on cancer cells, 2006.
40.
Al-WadeiH.A.UllahM.F. and Al-WadeiM., GABA (γ-aminobutyric acid), a non-protein amino acid counters the β-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: A review of experimental evidence, Molecular nutrition & food research55 (2011), 1745–1758.
41.
SchullerH.M. and Al-WadeiH.A., Neurotransmitter receptors as central regulators of pancreatic cancer, Future Oncology6 (2010), 221–228.
42.
ZhangX.ZhangR.ZhengY.ShenJ.XiaoD.LiJ.ShiX.HuangL.TangH. and LiuJ., Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer, Journal of Translational Medicine11 (2013), 102.
43.
LiuY.LiY.H.GuoF.J.WangJ.J.SunR.L.HuJ.Y. and LiG.C., Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor α3 subunit, World Journal of Gastroenterology14 (2008), 7175–7182.
44.
ShiH.ChenJ.LiY.LiG.ZhongR.DuD.MengR.KongW. and LuM., Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma, Oncotarget7 (2016), 21579–21590.
45.
LoriotA.TongelenA.V.BlancoJ.KlaessensS.CannuyerJ.BarenN.V.DecottigniesA. and SmetC., A novel cancer-germline transcript carrying pro-metastatic miR-105 and targeting miR-767 induced by DNA hypomethylation in tumors, Epigenetics9 (2014), 1163–1171.
46.
HuangY. and RaoA., Connections between TET proteins and aberrant DNA modification in cancer, Trends in Genetics30 (2014), 464.
47.
SimpsonA.J.CaballeroO.L.JungbluthA.ChenY.-T. and OldL.J., Cancer/testis antigens, gametogenesis and cancer, Nature Reviews Cancer5 (2005), 615–625.
48.
ScanlanM.J.GureA.O.JungbluthA.A.OldL.J. and ChenY.-T., Cancer/testis antigens: An expanding family of targets for cancer immunotherapy, Immunological Reviews188 (2002), 22–32.
49.
YaoJ.CaballeroO.L.YungW.A.WeinsteinJ.N.RigginsG.J.StrausbergR.L. and ZhaoQ., Tumor subtype-specific cancer–testis antigens as potential biomarkers and immunotherapeutic targets for cancers, Cancer Immunology Research2 (2014), 371–379.
50.
LinC.MakS.MeitnerP.A.WolfJ.M.BlumanE.M.BlockJ.A. and TerekR.M., Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma, Gene285 (2002), 269–278.
51.
OwensD.M. and KeyseS.M., Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases, Oncogene26 (2007), 3203–3213.
52.
BangY.J.JinH.K.KangS.H.KimJ.W. and YangY.C., Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma, Biochemical & Biophysical Research Communications250 (1998), 43–47.
53.
MönigS.P.BaldusS.E.HenneckenJ.K.SpieckerD.B.GrassG.SchneiderP.M.ThieleJ.DienesH.P. and HölscherA.H., Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma, Histopathology39 (2001), 597–602.
54.
WuC.W.ChenJ.H.KaoH.L.LiA.F.LaiC.H.ChiC.W. and LinW.C., PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma, Anticancer Research26 (2006), 1643–1649.
55.
GaoS.ZhouF.ChenZ.MaZ.JiaR.LiangS.ZhangM.ZhuX.ZhangP. and LuW., Gastric cardia adenocarcinoma microRNA profiling in Chinese patients, Tumor Biology37 (2016), 9411–9422.
56.
XiongL.WeiJ.ZhouR.MaoC. and GuoZ., Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data, Computers in Biology & Medicine43 (2013), 1252–1260.
57.
NewbyA.C., Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates, Cardiovascular Research69 (2006), 614–624.
